FORGOTTEN HISTORY: Cder | History Defined

TfL’s bailiffs are chasing me for a stranger’s unpaid Ulez fines

Now TFL is threatening to seize goods for four penalties for a car I’ve never owned

The Guardian - UK · Sep 28

Four Officials Who Decide Which Drugs, Vaccines and Vapes Reach Americans Now Hold Permanent FDA Appointments

HHS named permanent directors for the FDA centers governing drugs, biologics, and tobacco after a year of turnover. What each office controls.

Medical Daily · Sep 10

‘The FDA is a complete mess’: Trump makes fate of agency chief unclear as public trust plummets

Food and Drug Administration commissioner’s decisions have hurt staff morale and put his job in crosshairs

The Guardian - US · May 9

Here's How Citi Views Amylyx Pharma

Citi Research has raised the price target on Amylyx Pharmaceuticals Inc's (NASDAQ:AMLX) to $33 from $32, with a Buy rating. It says the small market opportunity for the newly approved amyotrophic lateral sclerosis (ALS) drug in Canada (~$100 million peak) bodes well for ongoing FDA review.  Availability in Canada and using ALSFRS-R data as the primary basis…

Benzinga · Jun 14, 2022

What's The FDA's Regulatory Impact On The Cannabis Industry? Find Out In This Webinar

What's the Food and Drug Administration's impact on the cannabis industry?

Benzinga · May 11, 2022

Why Ardelyx Shares Are Rising

Ardelyx Inc (NASDAQ: ARDX) shares are trading higher by 29.32% at $0.97 after the company reported it received an interim response from the OND, CDER and FDA for the company’s second level of appeal of the Complete Response Letter for XPHOZAH.

Benzinga · Apr 25, 2022